Sleep disorders in neurological diseases;Schlafstörungen bei neurologischen Erkrankungen

Nervenarzt

Volumn 86, Issue 6, 2015, Pages 759-771

  Kotterba, S ^a  

^a Klinikum Leer gGmbH   (Germany)

Author keywords

Disease symptoms; International classification of sleep disorders; Neurologic diseases; Polysomnography; Sleep disorders

Indexed keywords

ARTICLE; BREATHING DISORDER; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; HYPERSOMNIA; ICSD-2; INSOMNIA; NARCOLEPSY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NOCTURNAL SEIZURE; PARASOMNIA; PERIODIC LIMB MOVEMENT DISORDER; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SYMPTOM; COMPLICATION; NERVOUS SYSTEM DISEASES; POLYSOMNOGRAPHY; PROCEDURES; SLEEP WAKE DISORDERS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; NERVOUS SYSTEM DISEASES; POLYSOMNOGRAPHY; SLEEP WAKE DISORDERS;

EID: 84930958667     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-014-4204-6     Document Type: Article

References (39)

1. Happe S, Walther BW (Hrsg) (2009) Schlafmedizin in der Praxis- die internationale Klassifikation von Schlafstörungen in Fallberichten. ecomedMedizin. Heidelberg
2. AASM (2005) The international classification of sleep disorders: diagnostic and coding manual 2. Aufl. American Academy of Sleep Medicine, Westchester
3. Schenck CH, Montplaisir JY, Frauscher B (2013) Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder study Group. Sleep Med 14:795–806
4. Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinson disorder in 38 % of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46:388–393
5. Iranzo A, Tolosa E, Gelpi E, (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behavior disorder: an observational cohort study. Lancet Neurol 12:443–453
6. Mayer G (2014) Narkolepsie. Nervenarzt 85:26–34
7. Krenzer M, Oertel W, Trenkwalder C (2014) Praktische Diagnostik und Therapie des Restless-legs-Syndroms. Nervenarzt 85:19–25
8. Begutachtungsleitlinien zur Kraftfahrereignung (2014) BAST Bericht M115. Bundesanstalt für Straßenwesen, Bergisch Gladbach
9. Grimaldi D, Silvani A, Benarroch E (2014) Orexin/hypocretin system and autonomic control: new insights and clinical correlation. Neurology 82:271–278
10. Culebras A (2011) Other neurological disorders. In: Kryger MH, Roth T, Dement WC (Hrsg) Principles and Practice of Sleep Medicine, 5. Aufl. St. Louis, Saunders, S 1064–1074
11. Im KB, Strader S, Dyken ME (2012) Management of sleep disorders in stroke. Curr Treat Options Neurol 12(5):379–395
12. Nishino S, Kanbayashi T (2005) Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9(4):269–310
13. Martinez-Rodriguez JE, Lin L, Iranzo A (2003) Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep 26(3):287–290
14. Kotterba S (2009) Schlafbezogene Hypoventilation/Hypoxämie durch neuromuskuläre oder Brustwand-Erkrankungen. In Happe S, Walther BW (Hrsg) Schlafmedizin in der Praxis- die internationale Klassifikation von Schlafstörungen in Fallberichten. ecomedMedizin. Heidelberg, S 136–140
15. Eckert DJ, Jordan AS, Mercia P, Malhotra A (2007) Central sleep apnea: pathophysiology and treatment. Chest 131:595–607
16. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring systems of sleep stages of human subjects. US Department of Health, Education and Welfare. Bethesda
17. Kotterba S (2009) Zentrale Schlafapnoe durch Drogen, Medikamente und Substanzen. In: Happe S, Walther BW (Hrsg) Schlafmedizin in der Praxis- die internationale Klassifikation von Schlafstörungen in Fallberichten. ecomedMedizin. Heidelberg, S 85–87
18. Culebras A (2005) Sleep disorders and neuromuscular disorders. Neurol Clin 23(4):1209–1023
19. Ohayon M (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6:97–111
20. Riemann D, Baglioni C, Feige B (2014) Insomnien – Stand der Forschung. Nervenarzt 85:43–49
21. Schlack R, Hapke U, Maske U (2013) Häufigkeit und Verteilung von Schlafproblemen und Insomnie in der deutschen Erwachsenenbevölkerung. Bundesgesundheitsbl 56:740–748
22. Trojan DA, Arnold D, Collet J-P (2007) Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors. Mult Scler 13:985–995
23. Kotterba S (2009) Schlaf, zirkadiane Rhythmik und Fatigue. In: Penner IK (Hrsg) Fatigue bei Multipler Sklerose. Hippocampus Bad Honnef, S 87–94
24. Brown RF, Valpiani EM, Tennant CC (2009) Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother 82:41–56
25. Gómez-Choco MJ, Iranzo A, Blanco Y (2007) Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler 13:805–808
26. Italian REMS study GROUP, Manconi M, Ferini-Strambi L (2008) Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep 31:944–952
27. Trenkwalder C (2012) Restless Legs syndrome und Periodic Limb Movement Disorder (PLMD). In: Diener HC, Weimar C (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie, Thieme
28. Moreira NC, Damasceno RS, Medeiros CA (2008) Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients. Braz J Med Biol Res 41:923–927
29. Schölzel W, Schäfer C, Kotterba S (2011) Einfluss nächtlicher Bewegungsstörungen auf Fatigue bei Multipler Sklerose unter Therapie mit Interferon beta 1 b. Somnologie 15(Suppl 1):13
30. Veauthier C, Gaede G, Radbruch H (2013) Treatment of sleep disorders may improve fatigue in multiple sclerosis. Clin Neurol Neurosurg 115(9):1826–1830
31. Riemersma-van der Lek RF, Swaab DF, Twisk J (2008) Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities. A randomized controlled trial. JAMA 299:2642–2655
32. Kotterba S (2013) Forensische Aspekte der Parasomnien. Schlaf 2:79–82
33. Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C (2013) The coeruleus/subcoeruleus complex in rapid eye movement sleep behavior disorders in Parkinson’s disease. Brain 136:2120–2129
34. Cartwright RD (2010) Parasomnias due to medications or substances. In: Thorpy MJ, Plazzi G (Hrsg) The parasomnias and other sleep-related movement disorders. Cambridge Universitiy Press. Cambridge, S 42–53
35. Tinuper P, Bisulli F, Provini F (2012) The parasomnias: mechanisms and treatment. Epilespia 53(Suppl 7):12–19
36. Terzaghi M, Sartori I, Tassi L (2009) Evidence on dissociated arousal states during NREM parasomnia from an intracerebral neurophysiological study. Sleep 32:409–412
37. Provini F, Plazzi G, Tinuper P (1999) Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain 122:1017–1031
38. Manni R, Terzaghi M, Repetto A (2008) The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias: data from a tertiary sleep and epilepsy unit. Epilepsia 49:1581–1585
39. Aurora RN, Zak RS, Magnati RK (2010) Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 6(1):85–95